Oppenheimer & Co’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Oppenheimer & Co’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28,900	Closed	-$504K	–	1527
2020 Q4	$504K	Sell	28,900 -60,400	-68%	-$847K	0.01%	881
2020 Q3	$1.04M	Hold	89,300	–	–	0.03%	565
2020 Q2	$1.16M	Sell	89,300 -83,000	-48%	-$997K	0.03%	520
2020 Q1	$1.59M	Buy	172,300 +101,900	+145%	+$1.42M	0.05%	400
2019 Q4	$1.17M	Sell	70,400 -7,000	-9%	-$114K	0.03%	573
2019 Q3	$1.29M	Buy	77,400 +7,000	+10%	+$96.8K	0.04%	523
2019 Q2	$969K	Hold	70,400	–	–	0.03%	610
2019 Q1	$1.21M	Hold	70,400	–	–	0.03%	529
2018 Q4	$900K	Buy	+70,400	New	+$1.07M	0.03%	556

Oppenheimer & Co's OXFD Position: Q1 2021 in Review

Oppenheimer & Co sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 28,900 shares — an estimated $504K sold.

Oppenheimer & Co first reported a position in OXFD in Q4 2018 and held it in 9 quarters. The position peaked at $1.59M in Q1 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Oppenheimer & Co reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Oppenheimer & Co sold 28,900 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $504K.
Oppenheimer & Co first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2018 and held it in 9 quarters.
Oppenheimer & Co's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.59M in Q1 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Oppenheimer & Co's 13F filing for Q1 2021, filed 10 May 2021.